OmniAb Inc

NASDAQ:OABI

2.03

-0.03 (-1.46%)

5:24:56 PM EDT: $2.00 -0.03 (-1.48%)

Market Cap (Intraday)	242.07M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$5.33 Million
Adjusted EPS	-$0.15

See more estimates

10-Day MA	$1.95
50-Day MA	$1.61
200-Day MA	$2.98

See more pivots

OmniAb Inc Stock, NASDAQ:OABI

5980 Horton Street, Suite 600, Emeryville, California 94608

United States of America

Phone: +1.510.250.7800

Number of Employees: 114

http://www.omniab.com

Description

OmniAb, Inc. operates as a drug discovery company. It focuses on developing human monoclonal and bispecific therapeutic antibodies. Its platform includes the biological intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse. The company was founded on December 14, 2015 and is headquartered in Emeryville, CA.